We believe that NetScientific PLC (LON:NSCI) is well positioned to benefit from a recovery in the life sciences and technology sectors. The group has a broad portfolio of investments, including many that are generating sales and several others that are in late-stage clinical trials. NSCI raised £1.
NetScientific PLC (LON: NSCI) has assembled an exciting portfolio of emerging life science, healthcare and technology businesses. The company has evolved markedly following the acquisition of EMV Capital in August 2020, which has enabled it to shift the business model to a more capital-light approa
NetScientific (NSCI) is an active holding company that invests in, develops, commercialises and aims to realise returns from life sciences/healthcare, sustainability and technology companies. The share price has increased 150.1% year-to-date (YTD) as the company has delivered a strong performance o
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.